Related references
Note: Only part of the references are listed.STING-Dependent Type I IFN Production Inhibits CellMediated Immunity to Listeria monocytogenes
Kristina A. Archer et al.
PLOS PATHOGENS (2014)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability
Anu Wallecha et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Processing of Recombinant Listeria monocytogenes Proteins for MHC Class I Presentation Follows a Dedicated, High-Efficiency Pathway
Benjamin J. Wolf et al.
JOURNAL OF IMMUNOLOGY (2013)
Listeria monocytogenes (Lm)-LLO Immunotherapies Reduce the Immunosuppressive Activity of Myeloid-derived Suppressor Cells and Regulatory T Cells in the Tumor Microenvironment
Anu Wallecha et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer
Wilber Quispe-Tintaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclic di-AMP Is Critical for Listeria monocytogenes Growth, Cell Wall Homeostasis, and Establishment of Infection
Chelsea E. Witte et al.
MBIO (2013)
Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes
Patrick Guirnalda et al.
ONCOIMMUNOLOGY (2013)
ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer
Robert G Petit et al.
Journal for ImmunoTherapy of Cancer (2013)
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy
Mikayel Mkrtichyan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
Kelly Olino et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy
Laurence M. Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
Raquibul Hannan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Cervical Cancers Require the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncoprotein Even in the Presence of the Viral E6 Oncoprotein
Sean F. Jabbar et al.
CANCER RESEARCH (2012)
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
Dung T. Le et al.
CLINICAL CANCER RESEARCH (2012)
Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
Julia Karbach et al.
CLINICAL CANCER RESEARCH (2012)
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
Lee S. Rosen et al.
CLINICAL CANCER RESEARCH (2012)
Killed but metabolically active vaccines
Thomas W. Dubensky et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Hyperinduction of Host Beta Interferon by a Listeria monocytogenes Strain Naturally Overexpressing the Multidrug Efflux Pump MdrT
Kierstyn T. Schwartz et al.
INFECTION AND IMMUNITY (2012)
Immunotherapies for non-small-cell lung cancer and mesothelioma
Anish Thomas et al.
LANCET ONCOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma
Y. Chen et al.
ONCOGENE (2012)
Pharmaco-economic aspects of sipuleucel-T
Steven Simoens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human
V. Shahabi et al.
CANCER GENE THERAPY (2011)
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
Laurence M. Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis
Fang Zhou et al.
FEBS JOURNAL (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy
Laurence M. Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Listeria monocytogenes Triggers AIM2-Mediated Pyroptosis upon Infrequent Bacteriolysis in the Macrophage Cytosol
John-Demian Sauer et al.
CELL HOST & MICROBE (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cutting Edge: Cytosolic Bacterial DNA Activates the Inflammasome via Aim2
Sarah E. Warren et al.
JOURNAL OF IMMUNOLOGY (2010)
Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression
Hidenobu Ishizaki et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response
Joshua J. Woodward et al.
SCIENCE (2010)
Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy
Yvonne Paterson et al.
SEMINARS IN IMMUNOLOGY (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Vaccinia virus vaccines: Past, present and future
Bertram L. Jacobs et al.
ANTIVIRAL RESEARCH (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action
Sun Hee Kim et al.
CANCER RESEARCH (2009)
Intracellular Bacterial Vectors That Induce CD8+ T Cells with Similar Cytolytic Abilities but Disparate Memory Phenotypes Provide Contrasting Tumor Protection
Felicity C. Stark et al.
CANCER RESEARCH (2009)
Influence of Promoter, Gene Copy Number, and Preexisting Immunity on Humoral and Cellular Responses to a Vectored Antigen Delivered by a Salmonella enterica Vaccine
Manvendra Saxena et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
Anu Wallecha et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
Matthew M. Seavey et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization of Listeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice
Meredith L. Leong et al.
INFECTION AND IMMUNITY (2009)
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
Matthew M. Seavey et al.
JOURNAL OF IMMUNOLOGY (2009)
Priming and Activation of Human Ovarian and Breast Cancer-specific CD8+ T Cells by Polyvalent Listeria monocytogenes-based Vaccines
Gomathinayagam Sinnathamby et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
Paulo Cesar Maciag et al.
VACCINE (2009)
Suppression of Cell-Mediated Immunity following Recognition of Phagosome-Confined Bacteria
Keith S. Bahjat et al.
PLOS PATHOGENS (2009)
Prodrug converting enzyme gene delivery by L-monocytogenes
Jochen Stritzker et al.
BMC CANCER (2008)
Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases
S. H. Kim et al.
BRITISH JOURNAL OF CANCER (2008)
Development of a Listeria monocytogenes based vaccine against prostate cancer
Vafa Shahabi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature
Paulo Cesar Maciag et al.
CANCER RESEARCH (2008)
Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression
Laurel L. Lenz et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Pathways Mediating Resistance to Vascular Endothelial Growth Factor - Targeted Therapy
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2008)
KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
Mojca Skoberne et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Lipoproteins of Listeria monocytogenes are critical for virulence and TLR2-mediated immune activation
Silke Machata et al.
JOURNAL OF IMMUNOLOGY (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Salmonellae interplay with host cells
Andrea Haraga et al.
NATURE REVIEWS MICROBIOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction
Victoria E. Sevil Domenech et al.
VACCINE (2008)
Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors
Duane A. Sewell et al.
VACCINE (2008)
Activation of cytosolic phospholipase A2α in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2
Shahid Noor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
Nuran Bektas et al.
BREAST CANCER RESEARCH (2008)
Listeriolysin O secreted by Listeria monocytogenes into the host cell cytosol is degraded by the N-end rule pathway
Pamela Schnupf et al.
INFECTION AND IMMUNITY (2007)
Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis
Victria E. Sevil Domenech et al.
MICROBES AND INFECTION (2007)
Human papillomavirus and HPV vaccines: a review
F. T. Cutts et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines
Singh Reshma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy
Xiaohui Peng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Immunoediting sculpts tumor epitopes during immunotherapy
Reshma Singh et al.
CANCER RESEARCH (2007)
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses
Maciej Kmieciak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs
Jong-Hwan Park et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments
Mizuho Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer
Reshma Singh et al.
CANCER RESEARCH (2006)
Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy
Reshma Singh et al.
EXPERT REVIEW OF VACCINES (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines
Hiroyoshi Nishikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tissue-specificity of prostate specific antigens: Comparative analysis of transcript levels in prostate and non-prostatic tissues
Ana C. Cunha et al.
CANCER LETTERS (2006)
Pericytes and vascular stability
D von Tell et al.
EXPERIMENTAL CELL RESEARCH (2006)
In vivo bactofection:: Listeria can function as a DNA-cancer vaccine
NC Souders et al.
DNA AND CELL BIOLOGY (2006)
Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence
P Schnupf et al.
CELLULAR MICROBIOLOGY (2006)
Central nervous system tumor immunity generated by a recombinant Listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden
RM Prins et al.
NEUROSURGERY (2006)
Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion
Mickey Pentecost et al.
PLOS PATHOGENS (2006)
Central tolerance: Learning self-control in the thymus
KA Hogquist et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse
R Singh et al.
JOURNAL OF IMMUNOLOGY (2005)
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity
DG Brockstedt et al.
NATURE MEDICINE (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine
N Craft et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2
KW Bruhn et al.
VACCINE (2005)
Characterization of murine S-endoglin isoform and its effects on tumor development
E Pérez-Gómez et al.
ONCOGENE (2005)
Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors
ME Dominiecki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
C Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
KS Kobayashi et al.
SCIENCE (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
YA Yu et al.
NATURE BIOTECHNOLOGY (2004)
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CD4+CD25+ regulatory T cells that secrete TGFβ and IL-10 are preferentially induced by a vaccine vector
SF Hussain et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes
V Auerbuch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection
JA Carrero et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Type I interferon production enhances susceptibility to Listeria monocytogenes infection
RM O'Connell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists
JM Park et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7
DA Sewell et al.
CANCER RESEARCH (2004)
Listerta monocytogenes as a vaccine vector:: Virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy
H Starks et al.
JOURNAL OF IMMUNOLOGY (2004)
Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine
DA Sewell et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other vectors and DNA vaccines
T Verch et al.
INFECTION AND IMMUNITY (2004)
The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function
XH Peng et al.
JOURNAL OF IMMUNOLOGY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism
XL Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes
A Darji et al.
VACCINE (2003)
Role of CD4 T cell help and costimulation in CD8 T cell responses during listeria monocytogenes infection
DJ Shedlock et al.
JOURNAL OF IMMUNOLOGY (2003)
A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes
H Shen et al.
JOURNAL OF IMMUNOLOGY (2003)
Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress
CW Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria:: No role for either in macrophage listericidal activity
BT Edelson et al.
JOURNAL OF IMMUNOLOGY (2002)
The cell biology of Listeria monocytogenes infection:: the intersection of bacterial pathogenesis and cell-mediated immunity
DA Portnoy et al.
JOURNAL OF CELL BIOLOGY (2002)
A new strategy for the diagnosis of MAGE-expressing cancers
JW Park et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors
P Lauer et al.
JOURNAL OF BACTERIOLOGY (2002)
Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers:: a dose escalation study of oral inoculation
H Angelakopoulos et al.
INFECTION AND IMMUNITY (2002)
The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells
IJ Glomski et al.
JOURNAL OF CELL BIOLOGY (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma
M Tanaka et al.
MOLECULAR THERAPY (2002)
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma
JF Toso et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection
AR Tvinnereim et al.
INFECTION AND IMMUNITY (2002)
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16
GR Gunn et al.
JOURNAL OF IMMUNOLOGY (2001)
IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-γ
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2001)
Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge
M Mata et al.
VACCINE (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
IFN-γ can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2000)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
